16:54 EDT Tracon Pharmaceuticals files to sell common stock, warrants, no amount given
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TCON:
- TRACON Pharmaceuticals trading halted, news pending
- TRACON Pharmaceuticals Announces Reverse Stock Split
- Tracon Pharmaceuticals announces 1-for-20 reverse stock split
- Tracon Pharmaceuticals price target lowered to $3 from $6 at H.C. Wainwright
- Tracon says IDMC reccommends ENVASARC Phase 2 trial continue ‘as planned’
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue